Orwig’s experience augments Paterna’s goal to solve male infertility
January 8, 2024
Paterna Biosciences, a ground-breaking innovator in biotechnology and reproductive health, is pleased to announce Dr. Kyle Orwig has joined the company as a co-founder. As Paterna, a biotechnology company addressing male infertility by pioneering in vitro spermatogenesis, continues to push the boundaries of scientific discovery and advance its mission to improve human reproductive health, Orwig’s extensive expertise and contributions to in vitro spermatogenesis and male fertility preservation in oncofertility make him an invaluable asset to the company.